Atlas Trials

IMRT/Pemetrexed/Cisplatin in Esophageal Cancer

Clinical trial NCT01630174 · UNKNOWN

Trial details

NCT number
NCT01630174
Sponsor
Shandong Cancer Hospital and Institute
Status
UNKNOWN
Study type
OBSERVATIONAL
Esophageal Cancer
Start date
2009-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.